» Articles » PMID: 34385710

Somatic Mutations of GNA11 and GNAQ in CTNNB1-mutant Aldosterone-producing Adenomas Presenting in Puberty, Pregnancy or Menopause

Abstract

Most aldosterone-producing adenomas (APAs) have gain-of-function somatic mutations of ion channels or transporters. However, their frequency in aldosterone-producing cell clusters of normal adrenal gland suggests a requirement for codriver mutations in APAs. Here we identified gain-of-function mutations in both CTNNB1 and GNA11 by whole-exome sequencing of 3/41 APAs. Further sequencing of known CTNNB1-mutant APAs led to a total of 16 of 27 (59%) with a somatic p.Gln209His, p.Gln209Pro or p.Gln209Leu mutation of GNA11 or GNAQ. Solitary GNA11 mutations were found in hyperplastic zona glomerulosa adjacent to double-mutant APAs. Nine of ten patients in our UK/Irish cohort presented in puberty, pregnancy or menopause. Among multiple transcripts upregulated more than tenfold in double-mutant APAs was LHCGR, the receptor for luteinizing or pregnancy hormone (human chorionic gonadotropin). Transfections of adrenocortical cells demonstrated additive effects of GNA11 and CTNNB1 mutations on aldosterone secretion and expression of genes upregulated in double-mutant APAs. In adrenal cortex, GNA11/Q mutations appear clinically silent without a codriver mutation of CTNNB1.

Citing Articles

Adrenocortical stem cells in health and disease.

Chu Y, Setayesh J, Dumontet T, Krumeich L, Werner J, Moretti I Nat Rev Endocrinol. 2025; .

PMID: 40065108 DOI: 10.1038/s41574-025-01091-2.


Editorial: Advances in diagnostics and management of adrenal tumors.

Glinicki P, Sawicka-Gutaj N, Araujo-Castro M Front Endocrinol (Lausanne). 2025; 16:1543773.

PMID: 39950027 PMC: 11821480. DOI: 10.3389/fendo.2025.1543773.


Molecular and Genetics Perspectives on Primary Adrenocortical Hyperfunction Disorders.

Kim S, Chaudhary P, Kim S Int J Mol Sci. 2024; 25(21).

PMID: 39518893 PMC: 11545009. DOI: 10.3390/ijms252111341.


GNAQ/GNA11-Related Benign and Malignant Entities-A Common Histoembriologic Origin or a Tissue-Dependent Coincidence.

Pilch J, Mizera J, Tota M, Donizy P Cancers (Basel). 2024; 16(21).

PMID: 39518110 PMC: 11544895. DOI: 10.3390/cancers16213672.


Somatic , , and Mutations in Cat Aldosterone-Secreting Tumors.

Watson A, Syme H, Brown M Hypertension. 2024; 81(12):2489-2500.

PMID: 39429164 PMC: 11578054. DOI: 10.1161/HYPERTENSIONAHA.124.23501.


References
1.
Burton T, Mackenzie I, Balan K, Koo B, Bird N, Soloviev D . Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas. J Clin Endocrinol Metab. 2011; 97(1):100-9. DOI: 10.1210/jc.2011-1537. View

2.
Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagnere A . Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res. 2005; 65(17):7622-7. DOI: 10.1158/0008-5472.CAN-05-0593. View

3.
Murtha T, Carling T, Scholl U . Pregnancy, Primary Aldosteronism, and Somatic CTNNB1 Mutations. N Engl J Med. 2016; 374(15):1492-3. DOI: 10.1056/NEJMc1514508. View

4.
Kalinec G, Nazarali A, Hermouet S, Xu N, Gutkind J . Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells. Mol Cell Biol. 1992; 12(10):4687-93. PMC: 360395. DOI: 10.1128/mcb.12.10.4687-4693.1992. View

5.
Jakobsen J, Santoni-Rugiu E, Grauslund M, Melchior L, Sorensen J . Concomitant driver mutations in advanced -mutated non-small-cell lung cancer and their impact on erlotinib treatment. Oncotarget. 2018; 9(40):26195-26208. PMC: 5995236. DOI: 10.18632/oncotarget.25490. View